These results indicate that SMYD2-mediated methylation of PTEN at Lysine 313 diminishes the phosphorylation of PTEN at Serine 380, which subsequently results in AKT activation to promote breast cancer cell growth [36]. Here, PTEN is linked to breast carcinoma.